mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.004 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.005 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.006 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.008 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |